In addition, recent studies are linking low stomach acid levels with bacteria overgrowth
Specifically, the FDAs review of large trials and health records did not show an imbalance in suicide-related events between those on GLP-1 drugs and those on placebo (FDA update)
Compared to the placebo group, those who received the silymarin saw a "significant decrease" in their levels of key diabetic markers hemoglobin A1C, fasting blood sugar, total cholesterol, low-density lipoprotein ("bad") cholesterol, and triglycerides.17 The second is a recent review published in the Annals of Hepatology in 2021, much of which relates to silymarin's effect on insulin resistance,18 a prominent marker for type 2 diabetes.19 Two of the studies referenced in the review were animal studies that administered 26.25-100mg/kg of silybin to rat subjects (equivalent to around 366-1,395mg for an 86kg, or 190lb, human) across 6-12 weeks
Push on syringe plunger to release 2 to 3 drops of B12, ensuring that there is no more air in the barrel